Cargando…
PLA2G16 promotes osteosarcoma metastasis and drug resistance via the MAPK pathway
The prognosis of metastatic osteosarcoma is dismal and a better understanding of the mechanisms underlying disease progression is essential to improve treatment options and patient outcomes. We previously demonstrated Pla2g16 overexpression in mouse osteosarcoma contributes to metastasis phenotypes...
Autores principales: | Li, Lin, Liang, Shoulei, Wasylishen, Amanda R., Zhang, Yanqin, Yang, Xueli, Zhou, Bingzheng, Shan, Luling, Han, Xiuxin, Mu, Tianyang, Wang, Guowen, Xiong, Shunbin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951268/ https://www.ncbi.nlm.nih.gov/pubmed/26933804 http://dx.doi.org/10.18632/oncotarget.7694 |
Ejemplares similares
-
PLA2G16 Expression in Human Osteosarcoma Is Associated with Pulmonary Metastasis and Poor Prognosis
por: Liang, Shoulei, et al.
Publicado: (2015) -
Mitochondria-mediated apoptosis in mammals
por: Xiong, Shunbin, et al.
Publicado: (2014) -
Diagnostic investigations of PLA2G16 and CDH11 expression levels as independent prognostic markers of human osteosarcoma
por: Azarsina, Salman, et al.
Publicado: (2016) -
Construction and validation of a novel cuproptosis-mitochondrion prognostic model related with tumor immunity in osteosarcoma
por: Feng, Jinyan, et al.
Publicado: (2023) -
Lung metastases at the initial diagnosis of high-grade osteosarcoma: prevalence, risk factors and prognostic factors. A large population-based cohort study
por: Zhang, Chao, et al.
Publicado: (2020)